GESUNDHEIT ApS — Credit Rating and Financial Key Figures
CVR number: 34479925
Flæsketorvet 68, 1711 København V
info@74pharma.com
tel: 70702675
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 3 719.91 | 2 943.43 | 3 127.07 | 3 222.49 | 2 881.53 |
Employee benefit expenses | -2 535.87 | -3 011.30 | -2 407.36 | -2 934.11 | -2 975.22 |
Total depreciation | - 116.40 | - 157.20 | - 157.20 | - 157.20 | |
EBIT | 1 184.04 | - 184.28 | 562.52 | 131.19 | - 250.88 |
Other financial income | 26.07 | 15.51 | 22.85 | 25.20 | 24.52 |
Other financial expenses | -8.29 | -19.57 | -21.33 | -37.96 | -39.37 |
Pre-tax profit | 1 201.83 | - 188.34 | 564.04 | 118.43 | - 265.73 |
Income taxes | - 269.41 | 37.79 | - 137.22 | -38.17 | 50.32 |
Net earnings | 932.42 | - 150.54 | 426.82 | 80.25 | - 215.41 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 669.59 | 512.39 | 355.19 | 197.99 | |
Tangible assets total | 669.59 | 512.39 | 355.19 | 197.99 | |
Investments total | 96.00 | 96.00 | 78.60 | 78.60 | 78.60 |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 1 097.17 | 1 739.78 | 906.89 | 1 383.17 | 1 932.70 |
Current amounts owed by group member comp. | 260.68 | 320.03 | 389.03 | 553.30 | 714.06 |
Prepayments and accrued income | 5.10 | 5.10 | 4.04 | ||
Current other receivables | 174.98 | 109.00 | 249.66 | 138.74 | 59.98 |
Current deferred tax assets | 30.10 | 56.17 | |||
Short term receivables total | 1 532.83 | 2 204.00 | 1 550.67 | 2 079.25 | 2 762.92 |
Cash and bank deposits | 4 071.64 | 237.87 | 2 014.83 | 416.68 | 374.65 |
Cash and cash equivalents | 4 071.64 | 237.87 | 2 014.83 | 416.68 | 374.65 |
Balance sheet total (assets) | 5 700.47 | 3 207.46 | 4 156.49 | 2 929.71 | 3 414.16 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
Shares repurchased | 1 200.00 | 300.00 | |||
Retained earnings | - 116.71 | 815.71 | 365.17 | 791.99 | 872.24 |
Profit of the financial year | 932.42 | - 150.54 | 426.82 | 80.25 | - 215.41 |
Shareholders equity total | 2 095.71 | 745.17 | 1 171.99 | 952.24 | 736.83 |
Provisions | 7.69 | 22.57 | 32.05 | 37.90 | |
Non-current loans from credit institutions | 345.99 | 294.60 | 251.89 | 209.89 | |
Non-current deferred tax liabilities | 145.36 | 152.06 | 158.50 | 162.62 | |
Non-current liabilities total | 491.35 | 446.66 | 410.38 | 372.51 | |
Current loans from credit institutions | 86.53 | 134.58 | 96.87 | 133.33 | |
Advances received | 937.15 | 150.87 | 637.35 | ||
Current trade creditors | 1 143.67 | 449.30 | 661.96 | 422.73 | 487.97 |
Short-term deferred tax liabilities | 268.02 | 87.25 | 28.70 | ||
Other non-interest bearing current liabilities | 1 053.32 | 946.53 | 235.36 | 349.16 | 209.47 |
Accruals and deferred income | 1 132.05 | 488.58 | 458.98 | 486.73 | 798.80 |
Current liabilities total | 3 597.06 | 1 970.94 | 2 515.28 | 1 535.05 | 2 266.93 |
Balance sheet total (liabilities) | 5 700.47 | 3 207.46 | 4 156.49 | 2 929.71 | 3 414.16 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.